Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching.
作者信息
Grothe Jan, Sprute Rosanne, Cornely Oliver A
机构信息
University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.
University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.
出版信息
J Antimicrob Chemother. 2022 Jul 28;77(8):2308-2309. doi: 10.1093/jac/dkac098.
Abstract
摘要
相似文献
1
Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching.
J Antimicrob Chemother. 2022 Jul 28;77(8):2308-2309. doi: 10.1093/jac/dkac098.
2
Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching-authors' response.
J Antimicrob Chemother. 2022 Jul 28;77(8):2309-2311. doi: 10.1093/jac/dkac203.
3
Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching.
J Antimicrob Chemother. 2021 Dec 24;77(1):246-252. doi: 10.1093/jac/dkab372.
4
Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients.
Crit Care Med. 1996 Aug;24(8):1311-5. doi: 10.1097/00003246-199608000-00007.
5
Can Intra-abdominal Pressure Predict the Pharmacokinetics of Aminoglycosides in Critically Ill Patients With Intra-abdominal Sepsis?
Am J Ther. 2022;29(3):e376-e378. doi: 10.1097/MJT.0000000000001404. Epub 2021 Jun 11.
6
Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
Rev Esp Quimioter. 2012 Sep;25(3):206-15.
7
A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration.
Int J Antimicrob Agents. 2018 Oct;52(4):506-509. doi: 10.1016/j.ijantimicag.2018.07.008. Epub 2018 Jul 19.
8
Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
Diagn Microbiol Infect Dis. 2013 Jul;76(3):361-7. doi: 10.1016/j.diagmicrobio.2013.04.001.
9
Liposomal amphotericin B in critically ill paediatric patients.
J Clin Pharm Ther. 2012 Jun;37(3):291-5. doi: 10.1111/j.1365-2710.2011.01288.x. Epub 2011 Jul 21.
10
The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B.
J Infect Chemother. 2018 Sep;24(9):725-728. doi: 10.1016/j.jiac.2018.04.014.
本文引用的文献
1
Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching.
J Antimicrob Chemother. 2021 Dec 24;77(1):246-252. doi: 10.1093/jac/dkab372.
2
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
3
continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.
PLoS One. 2013 Oct 21;8(10):e77075. doi: 10.1371/journal.pone.0077075. eCollection 2013.
4
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37. doi: 10.1111/1469-0691.12039.
5
Amphotericin B: side effects and toxicity.
Rev Iberoam Micol. 2009 Dec 31;26(4):223-7. doi: 10.1016/j.riam.2009.06.003.
6
Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis.
J Antimicrob Chemother. 2007 May;59(5):952-6. doi: 10.1093/jac/dkm074. Epub 2007 Mar 27.
7
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
J Antimicrob Chemother. 2006 Apr;57(4):628-38. doi: 10.1093/jac/dki491. Epub 2006 Feb 3.
8
Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model.
Antimicrob Agents Chemother. 2001 Mar;45(3):922-6. doi: 10.1128/AAC.45.3.922-926.2001.
Zotero 插件